Please assess the completion status of the following clinical trial:

Trial Title: A Controlled Clinical Trial on The Use of a Specific Antivenom Against Envenoming by Bungarus Multicinctus

Study Design Characteristics:
- Allocation: None
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Envenomed by B. multicinctus~* Showed clinical signs of systemic envenomation (neuromuscular signs)~* Provided written informed consent (during the year 2006)~Exclusion Criteria:~* Pregnancy~* Patients had a known history of intolerance to equine serum

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- control group (Type: OTHER): As the antivenom was not yet clinically available until 2006, all patients included during the first two years (2004-2005) received supportive therapy only.
- antivenom group (Type: ACTIVE_COMPARATOR): The patients included during the third year (2006) were treated with antivenom therapy and supportive care.

Based on this trial design, predict the completion outcome and termination type (if applicable).